MoberlyJ.B., MujaisS., GehrT., HamburgerR., SpragueS., KucharskiA.Pharmacokinetics of icodextrin in peritoneal dialysis.Kidney Int Suppl2002; 81: S23–33.
2.
García-LópezE., AnderstamB., HeimbürgerO., AmiciG., WerynskiA., LindholmB.Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.Perit Dial Int2005; 25: 181–91.
3.
BlakeP., KredietR., FlessnerM.Controversies in peritoneal dialysis.Perit Dial Int2004; 24: 309–17.
4.
CaruanaR.J., BurkartJ., SegravesD., SmallwoodS., HaymoreJ., DisherB.Serum and peritoneal fluid amylase levels in CAPD. Normal values and clinical usefulness.Am J Nephrol1987; 7: 169–72.
5.
RippeB., LevinL.Computer simulations of ultrafiltration profiles for an icodextrin-based peritoneal fluid in CAPD.Kidney Int2000; 57: 2546–56.
6.
DaviesD.Kinetics of icodextrin.Perit Dial Int1994; 14(Suppl 2): S45–50.
7.
PosthumaN., ter WeeP.M., DonkerA.J., OeP.L., van DorpW., PeersE.M.Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell.Perit Dial Int1997; 17: 602–7.
